Morningstar

Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic ...

Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications Orum Therapeutics ( ...
abc27

AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with ...

– BLA based on data from the global Phase 1/2 CADENZA trial NORTH CHICAGO, Ill., Sept. 30, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced submission of a new Biologics License Application ...
Nasdaq

AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with ...

- BLA based on data from the global Phase 1/2 CADENZA trial PVEK is a CD123-targeting Antibody-Drug Conjugate (ADC) in clinical development for hematological malignancies (blood cancers), including ...
BioSpace

Avenzo Therapeutics Announces FDA Clearance of Investigational New Drug Application for AVZO-103, a Potential Best-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate

SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced clearance by the U.S. Food and ...
The National Law Review

Let’s Make it a Date – Best Method and the Filing Date of the Earliest Complete Application

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Business Wire

Gradient Announces $10 Million in Seed Funding Round to Revolutionize LLM Application Development

BURLINGAME, Calif.--(BUSINESS WIRE)--Gradient, an API platform for AI developers, announced today it has raised $10 million in seed funding led by Wing VC, with participation from Mango Capital and ...
Frontiers

Numerical optimization of large-scale monotone equations using the free-derivative spectral conjugate gradient method

This study introduced an efficient method for solving non-linear equations. Our approach enhances the traditional spectral conjugate gradient parameter, resulting in significant improvements in the ...
GitHub

Feature: LOBPCG the new eigensolver

I propose the development of a new feature within our software framework: the implementation of the Locally Optimal Block Preconditioned Conjugate Gradient (LOBPCG) algorithm as a general eigenvalue ...
Seeking Alpha

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated ...

- Initiation of CX-2051 Phase 1 clinical study in EpCAM positive tumors including colorectal cancer anticipated in 1H 2024 - - Initiation of CX-801 Phase 1 clinical study in solid tumors including ...